Literature DB >> 24445124

Industrial endocrine disruptors and polycystic ovary syndrome.

E Palioura1, E Diamanti-Kandarakis.   

Abstract

Polycystic ovary syndrome (PCOS) is a complex and enigmatic syndrome of unknown origin and etiology enclosing a broad spectrum of phenotypic manifestations. PCOS pathophysiology combines reproductive and metabolic abnormalities into a heterogeneous disorder that has pervasive and devastating health consequences. Inquiring the generative roots of the syndrome, it has become increasingly apparent the role of the environment as a determinant factor. Experimental exposure to industrial endocrine disruptors has been related with the impairment of normal reproductive function and metabolic regulation possibly favoring the development of or aggravating PCOS-resembling clinical disorders. Industrial chemicals may reflect the contributing role of an unfavorable environment to unveil PCOS characteristics in genetically predisposed individuals or further deteriorate the hormonal and fertility imbalances of PCOS-affected females.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24445124     DOI: 10.1007/BF03346762

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  46 in total

Review 1.  Impact of endocrine-disrupting compounds (EDCs) on female reproductive health.

Authors:  Paul A Fowler; Michelle Bellingham; Kevin D Sinclair; Neil P Evans; Paola Pocar; Bernd Fischer; Kristina Schaedlich; Juliane-Susanne Schmidt; Maria R Amezaga; Siladitya Bhattacharya; Stewart M Rhind; Peter J O'Shaughnessy
Journal:  Mol Cell Endocrinol       Date:  2011-10-28       Impact factor: 4.102

Review 2.  Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth.

Authors:  Evanthia Diamanti-Kandarakis; Christina Piperi
Journal:  Hum Reprod Update       Date:  2005-07-01       Impact factor: 15.610

3.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Authors:  E Diamanti-Kandarakis; C R Kouli; A T Bergiele; F A Filandra; T C Tsianateli; G G Spina; E D Zapanti; M I Bartzis
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

Review 4.  Follicular dynamics in the polycystic ovary syndrome.

Authors:  S Franks; H Mason; D Willis
Journal:  Mol Cell Endocrinol       Date:  2000-05-25       Impact factor: 4.102

Review 5.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

6.  Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction.

Authors:  Toru Takeuchi; Osamu Tsutsumi; Yumiko Ikezuki; Yasushi Takai; Yuji Taketani
Journal:  Endocr J       Date:  2004-04       Impact factor: 2.349

Review 7.  Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.

Authors:  Evanthia Diamanti-Kandarakis
Journal:  Expert Rev Mol Med       Date:  2008-01-30       Impact factor: 5.600

8.  Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults.

Authors:  Iain A Lang; Tamara S Galloway; Alan Scarlett; William E Henley; Michael Depledge; Robert B Wallace; David Melzer
Journal:  JAMA       Date:  2008-09-16       Impact factor: 56.272

9.  Endocrine disruptors and obesity: an examination of selected persistent organic pollutants in the NHANES 1999-2002 data.

Authors:  Mai A Elobeid; Miguel A Padilla; David W Brock; Douglas M Ruden; David B Allison
Journal:  Int J Environ Res Public Health       Date:  2010-07-23       Impact factor: 3.390

10.  The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance.

Authors:  Paloma Alonso-Magdalena; Sumiko Morimoto; Cristina Ripoll; Esther Fuentes; Angel Nadal
Journal:  Environ Health Perspect       Date:  2006-01       Impact factor: 9.031

View more
  6 in total

1.  Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS?

Authors:  M Šimková; J Vítků; L Kolátorová; J Vrbíková; M Vosátková; J Včelák; M Dušková
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

Review 2.  Bisphenol A environmental exposure and the detrimental effects on human metabolic health: is it necessary to revise the risk assessment in vulnerable population?

Authors:  R Valentino; V D'Esposito; F Ariemma; I Cimmino; F Beguinot; P Formisano
Journal:  J Endocrinol Invest       Date:  2015-06-24       Impact factor: 4.256

3.  Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome.

Authors:  Haoran Shen; Zhou Liang; Saihua Zheng; Xuelian Li
Journal:  Int J Mol Med       Date:  2017-09-20       Impact factor: 4.101

Review 4.  Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs.

Authors:  Michele d'Angelo; Vanessa Castelli; Maria Grazia Tupone; Mariano Catanesi; Andrea Antonosante; Reyes Dominguez-Benot; Rodolfo Ippoliti; Anna Maria Cimini; Elisabetta Benedetti
Journal:  Int J Mol Sci       Date:  2019-10-31       Impact factor: 5.923

5.  Polycystic ovarian syndrome: Environmental/occupational, lifestyle factors; an overview

Authors:  Chaoba Kshetrimayum; Anupama Sharma; Vineet Vashistha Mishra; Sunil Kumar
Journal:  J Turk Ger Gynecol Assoc       Date:  2019-03-01

Review 6.  Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing.

Authors:  Hosna Mohammad Sadeghi; Ida Adeli; Daniela Calina; Anca Oana Docea; Taraneh Mousavi; Marzieh Daniali; Shekoufeh Nikfar; Aristidis Tsatsakis; Mohammad Abdollahi
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.